Literature DB >> 3346681

Preclinical and subclinical events in motor neuron disease.

M Swash1, D Ingram.   

Abstract

It is suggested that in motor neuron disease there is a long preclinical period of relative tolerance and compensation before presentation with apparently focal features. During this phase the disease becomes disseminated through the motor system. The mode of acquisition of the disease, its relation to a possible genetic factor, and the processes leading to tolerance, to latency or progression, to the relative involvement of upper and lower motor neurons, to involvement of spinocerebellar pathways, and to asymmetry are fundamental problems in understanding the disease.

Entities:  

Mesh:

Year:  1988        PMID: 3346681      PMCID: PMC1031524          DOI: 10.1136/jnnp.51.2.165

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

1.  Collateral regeneration in partially denervated muscles.

Authors:  G WOHLFART
Journal:  Neurology       Date:  1958-03       Impact factor: 9.910

2.  Amyotrophic lateral sclerosis in Finland. II: Clinical characteristics.

Authors:  M Jokelainen
Journal:  Acta Neurol Scand       Date:  1977-09       Impact factor: 3.209

3.  Preservation of a certain motoneurone group of the sacral cord in amyotrophic lateral sclerosis: its clinical significance.

Authors:  T Mannen; M Iwata; Y Toyokura; K Nagashima
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-05       Impact factor: 10.154

4.  Morphometric quantification of the cervical limb motor cells in controls and in amyotrophic lateral sclerosis.

Authors:  H Tsukagoshi; N Yanagisawa; K Oguchi; K Nagashima; T Murakami
Journal:  J Neurol Sci       Date:  1979-05       Impact factor: 3.181

5.  The central nervous system in motor neurone disease.

Authors:  B Brownell; D R Oppenheimer; J T Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-06       Impact factor: 10.154

6.  A quantitative electrophysiological study of motor neurone disease.

Authors:  S Hansen; J P Ballantyne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-09       Impact factor: 10.154

7.  Pattern of involvement in the cervical segments in the early stage of motor neurone disease: a single fibre EMG study.

Authors:  M S Schwartz; M Swash
Journal:  Acta Neurol Scand       Date:  1982-05       Impact factor: 3.209

8.  Vulnerability of lower brachial myotomes in motor neurone disease: a clinical and single fibre EMG study.

Authors:  M Swash
Journal:  J Neurol Sci       Date:  1980-07       Impact factor: 3.181

9.  ALS in Rochester, Minnesota, 1925-1977.

Authors:  S M Juergens; L T Kurland; H Okazaki; D W Mulder
Journal:  Neurology       Date:  1980-05       Impact factor: 9.910

10.  Management of hypoventilation in motor neuron disease presenting with respiratory insufficiency.

Authors:  E D Sivak; E W Streib
Journal:  Ann Neurol       Date:  1980-02       Impact factor: 10.422

View more
  18 in total

Review 1.  Motor neuron disease.

Authors:  M Swash
Journal:  Postgrad Med J       Date:  1992-07       Impact factor: 2.401

Review 2.  How can we improve clinical trials in amyotrophic lateral sclerosis?

Authors:  Paul H Gordon; Vincent Meininger
Journal:  Nat Rev Neurol       Date:  2011-09-27       Impact factor: 42.937

Review 3.  ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration.

Authors:  John M Ravits; Albert R La Spada
Journal:  Neurology       Date:  2009-09-08       Impact factor: 9.910

4.  Superconditioning TMS for examining upper motor neuron function in MND.

Authors:  Blair Calancie; Eufrosina Young; Mary Lou Watson; Dongliang Wang; Natalia Alexeeva
Journal:  Exp Brain Res       Date:  2019-06-07       Impact factor: 1.972

Review 5.  Defining pre-symptomatic amyotrophic lateral sclerosis.

Authors:  Michael Benatar; Martin R Turner; Joanne Wuu
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2019-03-20       Impact factor: 4.092

6.  Functional neuroimaging at different disease stages reveals distinct phases of neuroplastic changes in amyotrophic lateral sclerosis.

Authors:  Bahram Mohammadi; Katja Kollewe; Amir Samii; Reinhard Dengler; Thomas F Münte
Journal:  Hum Brain Mapp       Date:  2011-05       Impact factor: 5.038

Review 7.  CSF markers in amyotrophic lateral sclerosis.

Authors:  Joanna Tarasiuk; Alina Kułakowska; Wiesław Drozdowski; Johannes Kornhuber; Piotr Lewczuk
Journal:  J Neural Transm (Vienna)       Date:  2012-05-04       Impact factor: 3.575

Review 8.  Persistent inward currents in spinal motoneurons: important for normal function but potentially harmful after spinal cord injury and in amyotrophic lateral sclerosis.

Authors:  S M ElBasiouny; J E Schuster; C J Heckman
Journal:  Clin Neurophysiol       Date:  2010-05-11       Impact factor: 3.708

9.  The onset of amyotrophic lateral sclerosis.

Authors:  M de Carvalho; M Swash
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

10.  The puzzling case of hyperexcitability in amyotrophic lateral sclerosis.

Authors:  Jong Seok Bae; Neil G Simon; Parvathi Menon; Steve Vucic; Matthew C Kiernan
Journal:  J Clin Neurol       Date:  2013-04-04       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.